The Geneticist's Role in Adult Congenital Heart Disease

Cardiology Clinics

Volumn 24, Issue 4, 2006, Pages 557-569

  Bernier, Francois P ^a   Spaetgens, Renee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALAGILLE SYNDROME; ANEUPLOIDY; CAREGIVER; CHROMOSOME 22Q; CHROMOSOME DELETION; CONGENITAL HEART DISEASE; DOWN SYNDROME; GENE; GENE MUTATION; GENETIC COUNSELING; HEART DEVELOPMENT; HOLT ORAM SYNDROME; HUMAN; NOONAN SYNDROME; PATHOGENESIS; PATIENT CARE; PRENATAL SCREENING; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SYNDROME CHARGE; SYNDROME VATER; TERATOGENESIS; TURNER SYNDROME; WILLIAMS BEUREN SYNDROME;

ADULT; CHROMOSOME DISORDERS; FEMALE; GENETIC COUNSELING; HEART DEFECTS, CONGENITAL; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RECURRENCE; SYNDROME;

EID: 33750736365     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2006.08.001     Document Type: Review

References (42)

1. Pelech A.N., and Broeckel U. Toward the etiologies of congenital heart diseases. Clin Perinatol 32 4 (2005) 825-844 [vii]
2. Goldmuntz E. The genetic contribution to congenital heart disease. Pediatr Clin North Am 51 6 (2004) 1721-1737 [x]
3. Grossfeld P.D. The genetics of congenital heart disease. J Nucl Cardiol 10 1 (2003) 71-76
4. Garg V., Kathiriya I.S., Barnes R., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424 6947 (2003) 443-447
5. Hirayama-Yamada K., Kamisago M., Akimoto K., et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 135 1 (2005) 47-52
6. Okubo A., Miyoshi O., Baba K., et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 41 7 (2004) e97
7. Sarkozy A., Conti E., Neri C., et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42 2 (2005) e16
8. Nemer G., Fadlalah F., Usta J., et al. A novel mutation in the GATA4 gene in patients with tetralogy of Fallot. Hum Mutat 27 3 (2006) 293-294
9. Ueyama T., Kasahara H., Ishiwata T., et al. Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis. Mol Cell Biol 23 24 (2003) 9222-9232
10. Schott J.J., Benson D.W., Basson C.T., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281 5373 (1998) 108-111
11. McElhinney D.B., Geiger E., Blinder J., et al. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42 9 (2003) 1650-1655
12. Hobbs C.A., Cleves M.A., Keith C., et al. NKX2.5 and congenital heart defects: a population-based study. Am J Med Genet A 134 2 (2005) 223-225
13. Robinson S.W., Morris C.D., Goldmuntz E., et al. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 72 4 (2003) 1047-1052
14. Gebbia M., Ferrero G.B., Pilia G., et al. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 17 3 (1997) 305-308
15. Ware S.M., Peng J., Zhu L., et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 74 1 (2004) 93-105
16. Krantz I.D., Smith R., Colliton R.P., et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet 84 1 (1999) 56-60
17. Tassabehji M., Metcalfe K., Donnai D., et al. Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum Mol Genet 6 7 (1997) 1029-1036
18. Meberg A., Otterstad J.E., Froland G., et al. Outcome of congenital heart defects-a population-based study. Acta Paediatr 89 11 (2000) 1344-1351
19. Online Mendelian Inheritance in Man. OMIM. McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2000. Available at: http://www.ncbi.nlm.nih.gov/omim/. Accessed March 15, 2006.
20. Mazzanti L., and Cacciari E. Congenital heart disease in patients with Turner's syndrome. Italian Study Group for Turner Syndrome (ISGTS). J Pediatr 133 5 (1998) 688-692
21. Elsheikh M., Casadei B., Conway G.S., et al. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 54 1 (2001) 69-73
22. Karnis M.F., Zimon A.E., Lalwani S.I., et al. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 80 3 (2003) 498-501
23. Perez E., and Sullivan K.E. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 14 6 (2002) 678-683
24. Antshel K.M., Kates W.R., Roizen N., et al. 22q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features keywords. Child Neuropsychol 11 1 (2005) 5-19
25. Merscher S., Funke B., Epstein J.A., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 4 (2001) 619-629
26. Yagi H., Furutani Y., Hamada H., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 362 9393 (2003) 1366-1373
27. Nishikawa T., Ishiyama S., Shimojo T., et al. Hypertrophic cardiomyopathy in Noonan syndrome. Acta Paediatr Jpn 38 1 (1996) 91-98
28. Tartaglia M., Mehler E.L., Goldberg R., et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29 4 (2001) 465-468
29. Basson C.T., Bachinsky D.R., Lin R.C., et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15 1 (1997) 30-35
30. Li L., Krantz I.D., Deng Y., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16 3 (1997) 243-251
31. McDermott D.A., Bressan M.C., He J., et al. TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res 58 5 (2005) 981-986
32. McElhinney D.B., Krantz I.D., Bason L., et al. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106 20 (2002) 2567-2574
33. Oda T., Elkahloun A.G., Pike B.L., et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16 3 (1997) 235-242
34. Krantz I.D., Colliton R.P., Genin A., et al. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 62 6 (1998) 1361-1369
35. Vissers L.E., van Ravenswaaij C.M., Admiraal R., et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36 9 (2004) 955-957
36. Uebing A., Steer P.J., Yentis S.M., et al. Pregnancy and congenital heart disease. BMJ 332 7538 (2006) 401-406
37. Beauchesne L.M., Warnes C.A., Connolly H.M., et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol 45 4 (2005) 595-598
38. Nora J.J. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 23 6 (1994) 1468-1471
39. Burn J., Brennan P., Little J., et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351 9099 (1998) 311-316
40. Cohen M.S., and Frommelt M.A. Does fetal diagnosis make a difference?. Clin Perinatol 32 4 (2005) 877-890 [viii]
41. Atzei A., Gajewska K., Huggon I.C., et al. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 26 2 (2005) 154-157
42. van Langen I.M., Birnie E., Schuurman E., et al. Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet 68 4 (2005) 360-368